The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma

被引:1
|
作者
Ning, Zhong-Hua [1 ,2 ]
Zhao, Wei [3 ]
Li, Xiao-Dong [1 ]
Chen, Lu-Jun [1 ]
Xu, Bin [1 ]
Gu, Wen-Dong [2 ]
Shao, Ying-Jie [2 ]
Xu, Yun [1 ]
Huang, Jin [2 ]
Pei, Hong-Lei [2 ]
Jiang, Jing-Ting [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou 213003, Peoples R China
[2] Soochow Univ, Affiliated Hosp 3, Dept Radiat Oncol, Changzhou 213003, Peoples R China
[3] Soochow Univ, Affiliated Hosp 3, Dept Pathol, Changzhou 213003, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2015年 / 8卷 / 06期
基金
中国国家自然科学基金;
关键词
Biomarkers; perineural invasion; prognosis; esophageal squamous cell carcinoma; postoperative radiotherapy; PROSTATE-CANCER; NEURAL INVASION; CURATIVE RESECTION; PANCREATIC-CANCER; RADIATION-THERAPY; SURVIVAL; ADJUVANT; CHEMORADIOTHERAPY; NEOADJUVANT; STROMA;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Prognosis of locally advanced esophageal squamous cell carcinoma (ESCC) remains dismal even after curative resection and adjuvant radiotherapy. New biomarkers for predicting prognosis and treatment outcomes are needed for improved treatment stratification of patients with locally advanced ESCC. The prognostic and treatment predictive significance of perineural invasion (PNI) in the locally advanced ESCC remains unclear. This study aimed to examine the effect of PNI on the outcomes of locally advanced ESCC patients after curative resection with or without postoperative radiotherapy (PORT). Patients and methods: We retrospectively reviewed 262 consecutive locally advanced ESCC patients who underwent curative resection. Tumors sections were re-evaluated for PNI by an independent pathologist blinded to the patients' outcomes. Overall survival (OS) and disease-free survival (DFS) were determined using the Kaplan-Meier method; univariate log-rank test and multivariate Cox proportional hazard model were used to evaluate the prognostic value of PNI. Results: Finally, 243 patients were analyzed and enrolled into this study, of which 132 received PORT. PNI was identified in 22.2% (54/243) of the pathologic sections. The 5-year DFS was favorable for PNI-negative patients versus PNI-positive patients (21.3% vs. 36.7%, respectively; P = 0.005). The 5-year OS was 40.3% for PNI-negative patients versus 21.7% for PNI-positive patients (P < 0.001). On multivariate analysis, PNI was an independent prognostic factor. In a subset analysis for patients received PORT, PNI was evaluated as a prognostic predictor as well (P < 0.05). In contrast to patients without PORT, PORT couldn't improve the disease recurrence and survival in locally advanced ESCC patients with PNI-positive (P > 0.05). Conclusions: PNI could serve as an independent prognostic factor and prognosticate treatment outcomes in locally advanced ESCC patients. The PNI status should be considered when stratifying high-risk locally advanced ESCC patients for adjuvant radiotherapy. Future prospective study is warranted to confirm our results.
引用
收藏
页码:6881 / 6890
页数:10
相关论文
共 50 条
  • [41] The Prognostic Analysis of Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma with Different Status of Lymph Node Metastasis
    Xu, X.
    Ma, X.
    Zhou, D.
    Bai, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2363 - S2363
  • [42] Combined nimotuzumab with chemoradiotherapy in patients with locally advanced or metastatic esophageal squamous cell carcinoma: A retrospective study
    Lai, Xiaojing
    Gu, Qing
    Zheng, Xiao
    Liu, Guan
    Feng, Wei
    Lin, Xiao
    Mao, Weimin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (05) : 89 - 95
  • [43] The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinoma
    Hirano, Hidekazu
    Boku, Narikazu
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (04) : 291 - 299
  • [44] The predictors of lymphopenia and its effects on survival in locally advanced esophageal squamous cell carcinoma
    Luo, Danjing
    Zhong, Qiulu
    Yue, Haiying
    Wang, Jue
    Liang, Qianfu
    Liu, Wenqi
    Zhu, Xiaodong
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [45] Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Lv, Huilai
    Tian, Yang
    Li, Jiachen
    Huang, Chao
    Sun, Bokang
    Gai, Chunyue
    Li, Zhenhua
    Tian, Ziqiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Recent Advances in Combination of Immunotherapy and Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Wang, Ruixi
    Liu, Shiliang
    Chen, Baoqing
    Xi, Mian
    CANCERS, 2022, 14 (20)
  • [47] Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma
    Leng, Xue-Feng
    Daiko, Hiroyuki
    Han, Yong-Tao
    Mao, You-Sheng
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1482 (01) : 213 - 224
  • [48] Prognostic value of circulating tumour DNA during post-radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma
    Wang, Xin
    Yu, Nuo
    Cheng, Guowei
    Zhang, Tao
    Wang, Jianyang
    Deng, Lei
    Li, Jiao
    Zhao, Xiaotian
    Xu, Yang
    Yang, Peng
    Bai, Na
    Li, Yin
    Bi, Nan
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (11):
  • [49] Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma
    Krstevska, V.
    JOURNAL OF BUON, 2009, 14 (03): : 361 - 373
  • [50] Perineural invasion correlates with postoperative distant metastasis and poor overall survival in patients with PT1-3N0M0 esophageal squamous cell carcinoma
    Sheng, Liming
    Ji, Yongling
    Du, Xianghui
    ONCOTARGETS AND THERAPY, 2015, 8 : 3153 - 3157